台湾从不吸烟者低剂量CT筛查的前瞻性队列研究
有肺癌家族史者浸润性肺癌检出率高于无家族史者。
核心结论
- 从不吸烟者基线LDCT后1年浸润性肺癌检出率较高,尤其有肺癌家族史者。
- 可能存在过度诊断,尤其原位腺癌。
- 一级亲属肺癌家族史显著增加肺癌及浸润性肺癌风险,且风险随年龄增长而增加。
研究设计与样本
- 全国性多中心前瞻性队列研究,在台湾17家三级医疗中心开展。
- 纳入12 011名55-75岁、从未吸烟或吸烟少于10包年且戒烟超过15年、具有至少一项肺癌危险因素且胸片阴性者。
- 基线LDCT后每年复查2年,之后每2年复查至6年,总随访8年;本次报告基线筛查后1年随访结果。
主要发现
- 多因素分析显示女性、肺癌家族史和年龄大于60岁与肺癌及浸润性肺癌风险增加相关;被动吸烟暴露、烹饪累积暴露、无通风烹饪和慢性肺病史与肺癌无关联。
关键数值与推荐
- 阳性扫描定义为平均直径大于6 mm的实性或部分实性结节,或平均直径大于5 mm的纯磨玻璃结节。
- 有肺癌家族史者中,一级亲属患病人数越多,肺癌风险越高;母亲或兄弟姐妹患肺癌者风险也增加。
临床怎么用
- 对从不吸烟但具肺癌家族史等高危因素者,可考虑基线LDCT筛查。
- 筛查阳性者需按结节特征进行后续侵入性诊断或手术。
- 应警惕原位腺癌的过度诊断可能。
局限性
- 仅报告基线筛查后1年随访结果,长期获益与危害尚未明确。
- 可能存在过度诊断,尤其原位腺癌。
- 无肺癌家族史者的肺癌危险因素仍需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In Taiwan, lung cancers occur predominantly in never-smokers, of whom nearly 60% have stage IV disease at diagnosis. We aimed to assess the efficacy of low-dose CT (LDCT) screening among never-smokers, who had other risk factors for lung cancer. METHODS: The Taiwan Lung Cancer Screening in Never-Smoker Trial (TALENT) was a nationwide, multicentre, prospective cohort study done at 17 tertiary medical centres in Taiwan. Eligible individuals had negative chest radiography, were aged 55-75 years, had never smoked or had smoked fewer than 10 pack-years and stopped smoking for more than 15 years (self-report), and had one of the following risk factors: a family history of lung cancer; passive smoke exposure; a history of pulmonary tuberculosis or chronic obstructive pulmonary disorders; a cooking index of 110 or higher; or cooking without using ventilation. Eligible participants underwent LDCT at baseline, then annually for 2 years, and then every 2 years up to 6 years thereafter, with follow-up assessments at each LDCT scan (ie, total follow-up of 8 years). A positive scan was defined as a solid or part-solid nodule larger than 6 mm in mean diameter or a pure ground-glass nodule larger than 5 mm in mean diameter. Lung cancer was diagnosed through invasive procedures, such as image-guided aspiration or biopsy or surgery. Here, we report the results of 1-year follow-up after LDCT screening at baseline. The primary outcome was lung cancer detection rate. The p value for detection rates was estimated by the χ2 test. Univariate and multivariable logistic regression analyses were used to assess the association between lung cancer incidence and each risk factor. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of LDCT screening were also assessed. This study is registered with ClinicalTrials.gov, NCT02611570, and is ongoing. FINDINGS: Between Dec 1, 2015, and July 31, 2019, 12 011 participants (8868 females) were enrolled, of whom 6009 had a family history of lung cancer. Among 12 011 LDCT scans done at baseline, 2094 (17·4%) were positive. Lung cancer was diagnosed in 318 (2·6%) of 12 011 participants (257 [2·1%] participants had invasive lung cancer and 61 [0·5%] had adenocarcinomas in situ). 317 of 318 participants had adenocarcinoma and 246 (77·4%) of 318 had stage I disease. The prevalence of invasive lung cancer was higher among participants with a family history of lung cancer (161 [2·7%] of 6009 participants) than in those without (96 [1·6%] of 6002 participants). In participants with a family history of lung cancer, the detection rate of invasive lung cancer increased significantly with age, whereas the detection rate of adenocarcinoma in situ remained stable. In multivariable analysis, female sex, a family history of lung cancer, and age older than 60 years were associated with an increased risk of lung cancer and invasive lung cancer; passive smoke exposure, cumulative exposure to cooking, cooking without ventilation, and a previous history of chronic lung diseases were not associated with lung cancer, even after stratification by family history of lung cancer. In participants with a family history of lung cancer, the higher the number of first-degree relatives affected, the higher the risk of lung cancer; participants whose mother or sibling had lung cancer were also at an increased risk. A positive LDCT scan had 92·1% sensitivity, 84·6% specificity, a PPV of 14·0%, and a NPV of 99·7% for lung cancer diagnosis. INTERPRETATION: TALENT had a high invasive lung cancer detection rate at 1 year after baseline LDCT scan. Overdiagnosis could have occurred, especially in participants diagnosed with adenocarcinoma in situ. In individuals who do not smoke, our findings suggest that a family history of lung cancer among first-degree relatives significantly increases the risk of lung cancer as well as the rate of invasive lung cancer with increasing age. Further research on risk factors for lung cancer in this population is needed, particularly for those without a family history of lung cancer. FUNDING: Ministry of Health and Welfare of Taiwan.
引用
- Chang GC, Chiu CH, Yu CJ, et al. Low-dose CT screening among never-smokers with or without a family history of lung cancer in Taiwan: a prospective cohort study. Lancet Respir Med. 2023. PMID: 38042167. doi:10.1016/S2213-2600(23)00338-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。